U.S. flag

An official website of the United States government

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 2

1.
Figure 1

Figure 1. From: Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.

Drug survival on etanercept, adalimumab and infliximab. Hazard ratio adjusted for age, sex, period, education level, baseline HAQ, disease duration, concomitant DMARD, and general frailty.

M Neovius, et al. Ann Rheum Dis. 2015 Feb;74(2):354-360.

CitationFull text

2.
Figure 2

Figure 2. From: Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.

Drug survival by TNF inhibitor initiation period. Hazard ratio adjusted for biologic drug, age, sex, period, education level, baseline HAQ, disease duration, concomitant DMARD, and general frailty.

M Neovius, et al. Ann Rheum Dis. 2015 Feb;74(2):354-360.

CitationFull text

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center